Advertisement

GLP-1s For Weight Loss: 4 Pros And 5 Cons To Consider

Discover how GLP-1 medications like Ozempic and Wegovy promote significant weight loss, their benefits, side effects, and who qualifies for treatment.

By Medha deb
Created on

GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda), mimic the glucagon-like peptide-1 hormone to regulate appetite, slow gastric emptying, and promote substantial weight loss of 15-25% in obese patients over one year. These medications, originally for type 2 diabetes, have transformed obesity management when combined with diet and exercise, though they require lifelong use to prevent regain and address risks like muscle loss.

What Are GLP-1s?

GLP-1s are injectable medications that activate GLP-1 receptors in the brain and gut, reducing hunger, increasing satiety, and improving blood sugar control. Liraglutide was the first FDA-approved for weight loss, achieving 10% body weight reduction in one-third of non-diabetic patients sustained for up to two years in the SCALE trial. Semaglutide follows with even greater efficacy, showing 14.9% loss in 68 weeks versus diet alone.

They work by inhibiting glucagon, stimulating insulin, and delaying digestion, leading to decreased caloric intake and gradual weight reduction peaking at 36-56 weeks. Unlike traditional diets, GLP-1s target hyperphagia, supporting both loss and maintenance when paired with a 500 kcal deficit and 150 minutes weekly activity.

How Do GLP-1s Work for Weight Loss?

These drugs reduce appetite via hindbrain action and lower energy expenditure thresholds after 10% loss, countering compensatory hunger. Clinical trials like STEP 1 for semaglutide demonstrate plateau after 20-36 weeks, with sustained benefits up to 104 weeks despite mild regain upon discontinuation.

Duration (Months)Effects
0 (Baseline)Appetite reduction, caloric intake drop
1-3Weight loss start, insulin sensitivity improves, HbA1c reduction
3-6Peak weight loss, cardiovascular risk drop
6-12Plateau, sustained HbA1c and heart benefits

Weight loss is greater in non-diabetics (up to 15%) than diabetics due to metabolic challenges. Half of users persist beyond 12 weeks, achieving meaningful 5%+ loss with health gains like reduced diabetes and hypertension risk.

Who Qualifies for GLP-1 Weight Loss Drugs?

Eligibility targets those with BMI 3030 (obesity) or BMI 3027 with comorbidities like hypertension, type 2 diabetes, or sleep apnea, especially after failed lifestyle attempts. They suit insulin-resistant individuals but not minor weight goals (10-15 lbs) due to cost and lifelong commitment. Prescribing by obesity experts improves persistence.

  • BMI 30+ or 27+ with conditions
  • History of unsuccessful diet/exercise
  • No mild overweight without risks

GLP-1 Weight Loss Drugs: Pros and Cons

Pros

  • 15-25% average loss in one year
  • Sustained up to 3 years, diabetes prevention in prediabetics
  • Cardiovascular benefits, reduced events
  • Improved insulin sensitivity, HbA1c

Cons

  • Muscle and lean mass loss (significant in STEP 1)
  • Weight regain on discontinuation
  • GI side effects: nausea, oily stools (low-fat diet advised)
  • Increased LDL in some >6-12 months
  • High cost, lifelong need

Younger patients (18-34) dropout sooner; gender neutral.

GLP-1 Side Effects and How to Manage Them

Common issues include nausea, vomiting, diarrhea; mitigated by low-fat diets and gradual dosing. Muscle loss requires protein focus and resistance training. Rare risks: pancreatitis, thyroid concerns (long-term unknown).

  • Nausea: Start low dose, eat small meals
  • GI Distress: Hydrate, low-fat foods
  • Muscle Loss: Protein 1.6g/kg, strength train

Preserving Muscle Mass on GLP-1s

GLP-1s cause fat and muscle loss; STEP trials confirm lean mass reduction. Counter with:

  • Adequate protein (regular balanced meals)
  • Strength training 2x/week
  • Monitor energy balance despite low appetite

Health at Every Size complements: joyful movement, intuitive eating for holistic health.

Lifestyle Changes to Maximize GLP-1 Results

Medications amplify but need habits:

Nutrition

  • Balanced meals with protein
  • Whole foods, portion control
  • Hydration

Exercise

  • 30 min walking daily
  • Strength 2x/week
  • Enjoyable activities

Sleep & Stress

  • 7-9 hours sleep
  • Meditation, support systems
  • Address emotional eating

Apps for tracking, oral alternatives, or surgery for BMI>40 considered.

GLP-1 Weight Loss Maintenance

Regimen alone insufficient; meds inhibit regain-driving hunger. Persistence key: 50% stay 12+ weeks. Post-meds, focus habits to sustain 5-15% loss.

Cost and Access to GLP-1 Drugs

High costs necessitate insurance for obesity indications; lifelong use implied. Younger dropout impacts value.

Alternatives to GLP-1s for Weight Loss

  • Lifestyle apps with coaching
  • Oral meds (non-injectable)
  • Bariatric surgery (BMI>40)
  • Health-focused behaviors: exercise enjoyment, nourishing foods

Frequently Asked Questions (FAQs)

What is the average weight loss on GLP-1s?

15-25% body weight in one year for obese patients; 14.9% with semaglutide in 68 weeks.

Do you regain weight after stopping GLP-1s?

Yes, regain occurs due to hunger rebound; lifelong use often needed.

Who should not take GLP-1 weight loss drugs?

Not for BMI<27 without conditions or minor goals; consult for thyroid history.

Can GLP-1s cause muscle loss?

Yes, preserve with protein and resistance training.

Are GLP-1s safe long-term?

Benefits outweigh risks short-term; monitor LDL, unknowns beyond 1-3 years.

References

  1. Weight Reduction with GLP-1 Agonists and Paths for … — PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11940170/
  2. Thinking about GLP-1 for weight loss? Here’s what to know — Baylor Scott & White Health. 2024. https://www.bswhealth.com/blog/glp-1-for-weight-loss
  3. Real-world trends in GLP-1 treatment persistence and prescribing … — Blue Cross Blue Shield. 2024. https://www.bcbs.com/media/pdf/BHI_Issue_Brief_GLP1_Trends.pdf
  4. Prescribing GLP-1 Agonists for Weight Loss: Wrestling With … — AAFP. 2024-10-01. https://www.aafp.org/pubs/afp/issues/2024/1000/editorial-glp-1-agonists-weight-loss.html
  5. I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know? — JAMA Internal Medicine. 2024. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2836527
Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb